Published online July 3, 2006
PEDIATRICS Vol. 118 No. 1 July 2006, pp. 436-437 (doi:10.1542/peds.2006-0721)

This Article Extract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Related articles in Pediatrics Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Yogev, R. Articles by Harisiades, J. P. Search for Related Content PubMed PubMed Citation Articles by Yogev, R. Articles by Harisiades, J. P. Related Collections Infectious Disease & Immunity Related AAP Red Book topics: Human Immunodeficiency Virus... Social Bookmarking                         What's this?

Opportunities to Prevent HIV Transmission in Newborns

Ram Yogev, MD
Section on Pediatric, Adolescent, and Maternal HIV

James P. Harisiades, MPH
Office of Child Advocacy,
Children's Memorial Hospital,
Chicago, IL 60614-3394

To the Editor.—

We fully concur with the assertion of Goldschmidt and Fogler that "pediatricians will be called on more and more to exercise their essential role in helping to eliminate perinatal HIV in the United States."¹ However, their commentary omitted the critical opportunity to prevent at least a third of mother-to-newborn HIV infection in vulnerable HIV-exposed newborns if they are started on anti-HIV prophylaxis within 48 hours after birth.² With the advent of rapid HIV testing that is now available, we have the opportunity to prevent HIV infection in newborns whose mothers' HIV status is unknown immediately after birth (ie, within 48 hours) by performing rapid testing (which yields results in <20–30 minutes) and administering immediate (and uninterrupted) antiretroviral prophylaxis.³ This can be done even if the mother has had no prenatal care or refuses HIV testing and treatment for herself before and during delivery.

Currently, many pregnant women in the United States refuse HIV testing during labor and delivery, even with intensive counseling. A recent study evaluating rapid HIV testing of pregnant women in labor found that only 84% accepted rapid testing.⁴ More compelling is that this particular population of women (who refuse to be tested) is at increased risk for being HIV positive.⁵

Since 1994, when science first demonstrated that transmission of HIV from mother to newborn could be prevented through prenatal testing and treatment, there still have been thousands of children infected with HIV in the United States that could have been prevented. Accordingly, postnatal interventions must also be used when prenatal efforts fail. Although testing, educating, and treating the pregnant woman before birth represent the most effective opportunity to prevent mother-to-newborn HIV transmission, routine newborn testing beginning at the earliest stages of life when the status of the mother is unknown at birth must be used by pediatricians to prevent needless HIV infection in accordance with our fundamental professional responsibility to optimize health outcomes for children. In states such as New York and Connecticut that routinely test newborns for HIV, mother-to-newborn HIV transmission has been reduced by >99%.

There is also an economical advantage. The rapid HIV test costs $10 to administer and the preventive treatment costs $75, in comparison to at least $10000 per year to treat a newborn with HIV, with life expectancies now exceeding 2 decades. Clearly, this savings in human suffering and cost should be compelling reasons for every pediatrician to immediately integrate this new opportunity (ie, rapid HIV testing of newborns whose mothers' HIV status is unknown) into standard practice. We hope that Drs Goldschmidt and Fogler agree.

REFERENCES

1. Goldschmidt RH, Fogler JA. Opportunities to prevent HIV transmission to newborns. Pediatrics. 2006;117 :208 –209[Free Full Text]
2. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med. 1998;339 :1409 –1414[Abstract/Free Full Text]
3. US Public Health Service Task Force. US Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States 2005. Available at: http://AIDSinfo.nih.gov. Accessed February 10, 2006
4. Bulterys M, Jamieson DJ, O'Sullivan MJ, et al. Rapid HIV-1 testing during labor: a multicenter study. JAMA. 2004;292 :219 –223[Abstract/Free Full Text]
5. Boxall EH, Smith N. Antenatal screening for HIV; are those who refuse testing at higher risk than those who accept testing? J Public Health. 2004;26 :285 –287

---

PEDIATRICS (ISSN 1098-4275). ©2006 by the American Academy of Pediatrics

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related articles in Pediatrics:

Opportunities to Prevent HIV Transmission in Newborns: In Reply

Jessica A. Fogler, Deborah Cohan, Shannon Weber, and Ronald H. Goldschmidt
Pediatrics 2006 118: 437. [Extract] [Full Text]  

This Article Extract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Related articles in Pediatrics Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Yogev, R. Articles by Harisiades, J. P. Search for Related Content PubMed PubMed Citation Articles by Yogev, R. Articles by Harisiades, J. P. Related Collections Infectious Disease & Immunity Related AAP Red Book topics: Human Immunodeficiency Virus... Social Bookmarking                         What's this?